4 April 2019

Cellular activities are dictated by proteins. Deciphering how proteins interact in a healthy or diseased state is a key area of interest in biology. Eventually, this will facilitate the development of drugs for many diseases including cancer, which is ultimately the result of misregulated protein homeostasis.

In recent years, affinity purification coupled to mass spectrometry (AP-MS) has been the preferred method to identify cellular protein-protein interactions. Unfortunately, AP-MS experiments typically require large amounts (millions of cells) of input material. For this reason, AP-MS studies are mostly restricted to cancer cell lines that can be grown in large quantities in vitro. Cristina Furlan and René Dirks from the groups of Michiel Vermeulen and Hendrik Marks, research theme Cancer development and immune defense, teamed up to address these limitations by developing a low input AP-MS workflow, called on-chip AP-MS, which can be used to perform AP-MS experiments using a few micrograms of lysate from a few thousand cells. This was achieved by implementing an AP-MS method in a automated, microfluidic device from the company Fluidigm using nanoliter volumes.

With the development of on-chip AP-MS, clinical samples, rare cell types and organoids, which are difficult to obtain in large quantities, can now be investigated using interaction proteomics studies. The field of mass spectrometry-based interaction proteomics is thus taking an important next step towards applications in biology and medicine which thus far, due to technical constraints, have remained elusive. This study was recently published in Nature Communications.

Related news items

European Commission Initiative on Breast Cancer (ECIBC) Guidelines

13 August 2019

In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer.

read more

Circulation publication for exercise physiologists

13 August 2019

Thijs Eijsvogels and Vincent Aengevaeren showed that exercise-incuded elevations of troponin concentrations are predictive of major adverse cardiovascular events and mortality.

read more

DELA, Radboudumc and Games for Health start a new project to fight loneliness among elderly using games

12 August 2019

More than half of people aged 75 and over feel their selves lonely every now and then. A special collaboration between DELA, Radboudumc, and Games for Health will investigate whether joined gaming between elderly and young people can alleviate this social problem.

read more

Floris Schreuder received Dekker grant

6 August 2019

Floris Schreuder received one of the ten Dekker grants from the Dutch Heart Foundation (Hartstichting).

read more

A warm welcome for a new RIMLS colleague Nico Sommerdijk

5 August 2019

As of 1 August we welcome Nico Sommerdijk as our new colleague at the RIMLS. Nico will join the department of Biochemistry, with his research group “Biochemistry of Mineralized Tissues”.

read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019

With over €43,000 on the counter, Kiemeney can see the Tour de France as a great success.

read more